NYSE:MDTMedical Equipment
Medtronic (MDT) Valuation Check As Stealth AXiS And Affera Platforms Reach New Regulatory And Clinical Milestones
Medtronic (MDT) is in focus after two medical technology updates: a CE mark for its Stealth AXiS surgical system in spine and cranial procedures, and fresh clinical milestones for its Affera cardiac arrhythmia platform.
See our latest analysis for Medtronic.
Despite a series of product milestones in cardiac care and surgical robotics, Medtronic’s 1 day share price return of 2.02% to US$80.97 comes against a weaker backdrop. The 90 day share price return shows a 21.36% decline and the 1 year...